LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | JW-7-24-1 | 3.33 | uM | LJP6 | 3 | B20 | 72 | hr | 2543 | 3120 | 5557 | 0.5614 | 0.1986 |
| SK-BR-3 | JW-7-24-1 | 10 | uM | LJP6 | 1 | B19 | 72 | hr | 2543 | 1268 | 5258 | 0.2411 | -0.4853 |
| SK-BR-3 | JW-7-24-1 | 10 | uM | LJP6 | 2 | B19 | 72 | hr | 2543 | 1722 | 5438 | 0.3167 | -0.2994 |
| SK-BR-3 | JW-7-24-1 | 10 | uM | LJP6 | 3 | B19 | 72 | hr | 2543 | 1666 | 5557 | 0.2998 | -0.3129 |
| SK-BR-3 | Dasatinib | 0.04 | uM | LJP6 | 1 | I06 | 72 | hr | 2543 | 5227 | 5258 | 0.9939 | 0.9884 |
| SK-BR-3 | Dasatinib | 0.04 | uM | LJP6 | 2 | I06 | 72 | hr | 2543 | 5449 | 5438 | 1.0020 | 1.0036 |
| SK-BR-3 | Dasatinib | 0.04 | uM | LJP6 | 3 | I06 | 72 | hr | 2543 | 5638 | 5557 | 1.0145 | 1.0257 |
| SK-BR-3 | Dasatinib | 0.04 | uM | LJP5 | 1 | D06 | 72 | hr | 2543 | 5826 | 5734 | 1.0160 | 1.0272 |
| SK-BR-3 | Dasatinib | 0.04 | uM | LJP5 | 2 | D06 | 72 | hr | 2543 | 5634 | 5761 | 0.9779 | 0.9624 |
| SK-BR-3 | Dasatinib | 0.04 | uM | LJP5 | 3 | D06 | 72 | hr | 2543 | 5925 | 5760 | 1.0285 | 1.0482 |
| SK-BR-3 | Dasatinib | 0.12 | uM | LJP6 | 1 | I05 | 72 | hr | 2543 | 4602 | 5258 | 0.8751 | 0.7609 |
| SK-BR-3 | Dasatinib | 0.12 | uM | LJP6 | 2 | I05 | 72 | hr | 2543 | 5340 | 5438 | 0.9820 | 0.9671 |
| SK-BR-3 | Dasatinib | 0.12 | uM | LJP6 | 3 | I05 | 72 | hr | 2543 | 5155 | 5557 | 0.9276 | 0.8710 |
| SK-BR-3 | Dasatinib | 0.12 | uM | LJP5 | 1 | D05 | 72 | hr | 2543 | 5363 | 5734 | 0.9352 | 0.8890 |
| SK-BR-3 | Dasatinib | 0.12 | uM | LJP5 | 2 | D05 | 72 | hr | 2543 | 5322 | 5761 | 0.9237 | 0.8699 |
| SK-BR-3 | Dasatinib | 0.12 | uM | LJP5 | 3 | D05 | 72 | hr | 2543 | 5663 | 5760 | 0.9830 | 0.9712 |
| SK-BR-3 | Dasatinib | 0.37 | uM | LJP6 | 1 | I04 | 72 | hr | 2543 | 4765 | 5258 | 0.9061 | 0.8204 |
| SK-BR-3 | Dasatinib | 0.37 | uM | LJP6 | 2 | I04 | 72 | hr | 2543 | 5040 | 5438 | 0.9268 | 0.8660 |
| SK-BR-3 | Dasatinib | 0.37 | uM | LJP6 | 3 | I04 | 72 | hr | 2543 | 5293 | 5557 | 0.9524 | 0.9154 |
| SK-BR-3 | Dasatinib | 0.37 | uM | LJP5 | 1 | D04 | 72 | hr | 2543 | 5393 | 5734 | 0.9405 | 0.8980 |
| SK-BR-3 | Dasatinib | 0.37 | uM | LJP5 | 2 | D04 | 72 | hr | 2543 | 5594 | 5761 | 0.9709 | 0.9506 |
| SK-BR-3 | Dasatinib | 0.37 | uM | LJP5 | 3 | D04 | 72 | hr | 2543 | 5633 | 5760 | 0.9778 | 0.9623 |
| SK-BR-3 | Dasatinib | 1.11 | uM | LJP6 | 1 | I03 | 72 | hr | 2543 | 4248 | 5258 | 0.8078 | 0.6314 |
| SK-BR-3 | Dasatinib | 1.11 | uM | LJP6 | 2 | I03 | 72 | hr | 2543 | 4467 | 5438 | 0.8214 | 0.6715 |
| SK-BR-3 | Dasatinib | 1.11 | uM | LJP6 | 3 | I03 | 72 | hr | 2543 | 5093 | 5557 | 0.9164 | 0.8511 |